Editor's Picks: Gold, Silver Prices Take a Hit, Russia Makes Bold Gold Claim united statesgold investingsilver investingsilver outlookgold outlookchris blasiiranrussiaCharlotte McLeod05 June
Tech Weekly: Heavy Selling Results in Weekly Loss for Nasdaq united statesnyse stocksnasdaq stockstechnology investingMeagen Seatter26 June
Leading Edge Secures Rare Earths Mining Lease for Norra Kärr swedenrare earth outlookrare earth investingrare earth stockstsxv stocksrare earth developmentGiann Liguid6h
Victory Metals Awarded AU$350,000 for Rare Earths Work rare earth investingrare earth stocksasx stockswestern australiaaustraliaGabrielle De La Cruz6h
Cannabis Crossroads: What Investors Need to Watch Ahead of Historic DEA Hearing united statescannabis outlookMeagen Seatter7h
Zymeworks Expands into Respiratory Market with Theravance Buyout united statespharmaceutical investingbiotech stocksbiotech investingpharma stocksnasdaq stocksGiann Liguid7h
Top 5 Canadian Mining Stocks This Week: Grande Portage Resources Gains 32 Percent gold explorationgold investingcse stockstsxv stocksgold stockscanadabritish columbiatsx stocksbest performing stocksontarioquébecgreenlandguyanaDean Belder26 June
Titan Mining to Partner with US Army for Graphite-processing Facilities graphite stocksgraphite investingtsx stocksnyse stocksgraphite miningnew yorkunited statesGiann Liguid26 June
Crypto Market Update: Strategy Outlines Rules for Selling Bitcoin Reserves financeblockchain investingtradingunited statesMeagen SeatterGiann Liguid26 June
Top 5 Australian Mining Stocks This Week: Lakes Blue Energy Rises as Wombat Gas Field Progresses oil and gas investingaustraliaasx stockswestern australiaqueenslandoil and gas developmentoil and gas stocksnorthern territorycubacambodiathailandpapua new guineaGabrielle De La Cruz25 June
Rhona O'Connell: Gold Price Drop — Why it Happened, What's Next gold outlookrhona o'connellgold investingCharlotte McLeod25 June
Merck KGaA to Acquire Bio-Techne in US$11.3 Billion Deal pharmaceutical stocksnasdaq stocksm&apharmaceutical investingGiann Liguid25 June